Fungemia due to Rhodotorula mucilaginosa after allogeneic hematopoietic stem cell transplantation

Transplant Infectious Disease

Volumn 14, Issue 1, 2012, Pages 91-94

  Mori, T ^a   Nakamura, Y ^a,b   Kato, J ^a   Sugita, K ^c   Murata, M ^a   Kamei, K ^d   Okamoto, S ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KEIO UNIVERSITY HOSPITAL   (Japan)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Central line; Fungemia; Myelodysplastic syndrome; Rhodotorula mucilaginosa

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ECHINOCANDIN; FLUCONAZOLE; FLUDARABINE; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; MICAFUNGIN; STEROID; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG MEGADOSE; DRUG SUBSTITUTION; FEVER; FUNGEMIA; GRAFT RECIPIENT; HUMAN; MALE; MEDICAL LITERATURE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROPHYLAXIS; RHODOTORULA MUCILAGINOSA;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; FUNGEMIA; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MYCOSES; MYELODYSPLASTIC SYNDROMES; RHODOTORULA; TRANSPLANTATION, HOMOLOGOUS; UNRELATED DONORS;

EID: 84857055939     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2011.00647.x     Document Type: Article

References (17)

1. Tuon FF, Costa SF. Rhodotorula infection. A systematic review of 128 cases from literature. Rev Iberoam Micol 2008; 25: 135-140.
2. Kiehn TE, Gorey E, Brown AE, Edwards FF, Armstrong D. Sepsis due to Rhodotorula related to use of indwelling central venous catheters. Clin Infect Dis 1992; 14: 841-846.
3. Tuon FF, de Almeida GM, Costa SF. Central venous catheter-associated fungemia due to Rhodotorula spp. - a systematic review. Med Mycol 2007; 45: 441-447.
4. García-Suárez J, Gómez-Herruz P, Cuadros JA, Burgaleta C. Epidemiology and outcome of Rhodotorula infection in haematological patients. Mycoses Epub, Mar 11, 2010.
5. Krcmery V, Krupova I, Denning DW. Invasive yeast infections other than Candida spp. in acute leukaemia. J Hosp Infect 1999; 41: 181-194.
6. Sheu MJ, Wang CC, Wang CC, Shi WJ, Chu ML. Rhodotorula septicemia: report of a case. J Formos Med Assoc 1994; 93: 645-647.
7. Alliot C, Desablens B, Garidi R, Tabuteau S. Opportunistic infection with Rhodotorula in cancer patients treated by chemotherapy: two case reports. Clin Oncol 2000; 12: 115-117.
8. Petrocheilou-Paschou V, Prifti H, Kostis E, Papadimitriou C, Dimopoulos MA, Stamatelopoulos S. Rhodotorula septicemia: case report and minireview. Clin Microbiol Infect 2001; 7: 100-102.
9. Zaas AK, Boyce M, Schell W, Lodge BA, Miller JL, Perfect JR. Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates. J Clin Microbiol 2003; 41: 5233-5235.
10. Pasqualotto GC, Copetti FA, Meneses CF, Machado AR, Brunetto AL. Infection by Rhodotorula sp. in children receiving treatment for malignant diseases. J Pediatr Hematol Oncol 2005; 27: 232-233.
11. Lunardi LW, Aquino VR, Zimerman RA, Goldani LZ. Epidemiology and outcome of Rhodotorula fungemia in a tertiary care hospital. Clin Infect Dis 2006; 43: e60-e63.
12. García-Suárez J, Gómez-Herruz P, Cuadros JA, Guillén H, Burgaleta C. Rhodotorula mucilaginosa catheter-related fungaemia in a patient with multiple myeloma. Mycoses Epub Dec 23, 2009.
13. Preney L, Théraud M, Guiguen C, Gangneux JP. Experimental evaluation of antifungal and antiseptic agents against Rhodotorula spp. Mycoses 2003; 46: 492-495.
14. Diekema DJ, Petroelje B, Messer SA, Hollis RJ, Pfaller MA. Activities of available and investigational antifungal agents against Rhodotorula species. J Clin Microbiol 2005; 43: 476-478.
15. Gomez-Lopez A, Mellado E, Rodriguez-Tudela JL, Cuenca-Estrella M. Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review. J Antimicrob Chemother 2005; 55: 312-316.
16. Pfaller MA, Diekema DJ, Gibbs DL, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol 2009; 47: 117-123.
17. Carrillo-Muñoz AJ, Tur-Tur C, Hernández-Molina JM, et al. Antifungal activity of posaconazole against Candida spp. and non-Candida clinical yeasts isolates. Rev Esp Quimioter 2010; 23: 122-125.